Loyal

Loyal is a clinical-stage veterinary medicine company developing longevity drugs for dogs. Our mission is to help dogs live longer, healthier lives.

Health and bio

Loyal raised $100M in a Series B+ round announced February 11, 2026, according to businesswire.com. Across 2 sourced rounds it has raised $122M in total. Investors in that round: The Longevity Fund.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. February 11, 2026
   Series B+ · $100M
   TThe Longevity Fund (lead)
   Source: businesswire.com (startups.gallery listing)
3. February 26, 2025
   Series B+ · $22M
   CCollaborative Fund (lead)
   Source: finsmes.com (startups.gallery listing)

Investors

• BBain Capital Ventures
• BBoxGroup
• CCollaborative Fund
• KKhosla Ventures
• QQuiet Capital
• SSunflower Capital
• TThe Longevity Fund

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/loyal.